Huadong Medicine Co., Ltd
000963
Rang in Aktien
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Aktienkurs
$3.89
Marktkapitalisierung
$6.83B
Veränderung (1 Tag)
-2.22%
Veränderung (1 Jahr)
-30.58%
Land
CN
Handel Huadong Medicine Co., Ltd (000963)
Kategorie
Healthcare
Umsatz von Huadong Medicine Co., Ltd (000963)
Umsatz im Jun 2026 TTM: $6.59B
Laut den aktuellen Finanzberichten von Huadong Medicine Co., Ltd beträgt der derzeitige Umsatz des Unternehmens (TTM) $6.59B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $5.74B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $5.74B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Huadong Medicine Co., Ltd von 2001 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $6.59B | 5.71% |
| 2025 | $6.23B | 8.57% |
| 2024 | $5.74B | 0.04% |
| 2023 | $5.74B | 4.96% |
| 2022 | $5.47B | 0.54% |
| 2021 | $5.44B | 5.47% |
| 2020 | $5.16B | 1.29% |
| 2019 | $5.09B | 14.19% |
| 2018 | $4.46B | 4.21% |
| 2017 | $4.28B | 17.02% |
| 2016 | $3.66B | 9.25% |
| 2015 | $3.35B | 9.38% |
| 2014 | $3.06B | 10.99% |
| 2013 | $2.76B | 17.88% |
| 2012 | $2.34B | 32.41% |
| 2011 | $1.77B | 29.90% |
| 2010 | $1.36B | 18.60% |
| 2009 | $1.15B | 29.99% |
| 2008 | $881.72M | 32.65% |
| 2007 | $664.70M | 30.76% |
| 2006 | $508.34M | 17.77% |
| 2005 | $431.65M | 23.93% |
| 2004 | $348.31M | 23.94% |
| 2003 | $281.03M | 12.60% |
| 2002 | $249.58M | 9.48% |
| 2001 | $227.97M | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $29.24B | 343.74% |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 0.34% |
IN
|
